Vote Scores

Home / Companies / SILENCE THERAPEUTICS PLC / 16 Jun 2026

Meeting · year to 30 June 202653 filers reporting

SILENCE THERAPEUTICS PLC: meeting of 16 Jun 2026

Votes reported on Form N-PX, item by item

53 Form N-PX filers reported votes at the SILENCE THERAPEUTICS PLC meeting of 16 Jun 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 75.0% of reported votes for; 4 filers withheld from or voted against at least one nominee.

16 vote records from 8 filers. 0 of the 8 filers that marked the item either way voted against management.

50.0% for0.0% against50.0% other0.0% against management8 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

82 vote records from 53 filers. 1 of the 46 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.

83.0% for0.0% against17.0% other2.2% against management53 filers100.0% for0.0% against0.0% against management16,521,469 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

24 vote records from 8 filers. 0 of the 8 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management8 filers100.0% for0.0% against0.0% against management549,249 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

7 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management7 filers100.0% for0.0% against0.0% against management26,830 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

16 vote records from 8 filers. 0 of the 8 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management8 filers100.0% for0.0% against0.0% against management366,166 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
BlackRock and iSharesSplit or no voteForFor
FidelityForForFor
State Street and SPDRSplit or no voteForFor
InvescoSplit or no voteForFor
Nuveen and TIAASplit or no voteForFor
ProShares and ProFundsForForFor
Columbia ThreadneedleNo reportForNo report
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the SILENCE THERAPEUTICS PLC meeting?

53 Form N-PX filers reported votes at the meeting of 16 Jun 2026. On say-on-pay, 1 of 46 voted against management (2.2%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by SILENCE THERAPEUTICS PLC on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for SILENCE THERAPEUTICS PLC

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing SILENCE THERAPEUTICS PLC with a meeting date within three days of 16 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.